Board Regulation

Series 2025
Board Regulation No. 1 Inclusion of Butonitazene in the List of Dangerous Drugs
Board Regulation
No. 2		 Inclusion of 3-Chloromethcathinone (3-CMC) in the List of the Dangerous Drugs
Board Regulation
No. 3		 Inclusion of Dipentylone in the List of Dangerous Drugs
Board Regulation
No. 4		 Inclusion of 2-Flourodeschloroketamine in the List of Dangerous Drugs
Board Regulation
No. 5		 Inclusion of Bromazolam in the List of Dangerous Drugs
Board Regulation
No. 6		 Inclusion of 4-Piperidone and 1-BOC-4-Piperidone in the List of Dangerous Drugs
Board Regulation
No. 7		 Inclusion of P-2-P Methyl Glycidic Acid and Eight of its Esters (Methyl Ester, ethyl Ester, Propyl Ester, Isopropyl Ester, Butyl Ester, Isobutyl Ester, Sec-Butyl Ester, and Tert-Butyl Ester) in the List of Dangerous Drugs
Board Regulation
No. 8		 Inclusion of Ethyl Ester of 3, 4-MDP-2P Methyl Glycidic Acid “PMK Ethyl Glycidate” and its Six Additional Esters (Propyl Ester, Isopropyl Ester, Butyl Ester, Isobutyl Ester, Sec-Butyl Ester, Tert Butyl Ester) in the List of Dangerous Drugs
Board Regulation
No. 9		 Creation of a Committee for the Assessment of Seized Controlled Chemicals and Laboratory Equipment for Medical, Scientific, Training, and Other Lawful Purposes
Board Regulation
No. 10		 Preemptive Response to Emerging Public Health Concerns through Temporary Authorization of Ordinary Prescriptions for Dangerous Drugs
Board Regulation
No. 11		 Amending Dangerous Drugs Board Regulation No. 2, Series of 2020 Re: Guidelines in the Nationwide Implementation of Drug Clearing Program in Controlled Facilities for Persons Deprived of Liberty
Board Regulation
No. 12		 Creation of the Cyber and Information Technology Service in the Philippine Drug Enforcement Agency
Board Regulation
No. 13		 Inclusion of MDMB-4en-PIMACA in Schedule I of the 1971 UN Convention on Psychotropic Substances
Board Regulation
No. 14		 INCLUSION OF 4-AP, 1-Boc-4-AP AND NORFENTANYL TO THE LIST OF CONTROLLED PRECURSOR AND ESSENTIAL CHEMICALS
Board Regulation
No. 15		 RECLASSIFICATION OF 4-PIPERIDONE AND I-BOC-4-PIPERIDONE FROM THE LIST OF DANGEROUS DRUGS TO THE LIST OF CONTROLLED PRECURSORS AND ESSENTIAL CHEMICALS
Board Regulation
No. 16		 RECLASSIFICATION OF P-2-P METHYL GLYCIDIC ACID AND EIGHT OF ITS ESTERS (METHYL ESTER, ETHYL ESTER, PROPYL ESTER, ISOPROPYL ESTER, BUTYL ESTER, ISOBUTYL ESTER, SEC-BUTYL ESTER AND TERT-BUTYL ESTER) FROM DANGEROUS DRUGS TO CONTROLLED PRECURSORS AND ESSENTIAL CHEMICALS
Board Regulation
No. 17		 RECLASSIFICATION OF 3,4-MDP-2-P METHYL GLYCIDIC ACID AND ITS SEVEN ESTERS (ETHYL ESTER, PROPYL ESTER, ISOPROPYL ESTER, BUTYL ESTER, ISOBUTYL ESTER, SEC-BUTYL ESTER, TERT-BUTYL ESTER FROM THE LIST OF DANGEROUS DRUGS TO THE LIST OF CONTROLLED PRECURSORS AND ESSENTIAL CHEMICALS

 

Series 2024
Board Regulation No. 1 Creating a Technical Working Group for the Executive Review of Republic Act No. 9165 or the Comprehensive Dangerous Drugs Act of 2002
Board Regulation
No. 2		 Extension of the Provisional Removal of Lianhua Qingwen from the List of Dangerous Drugs for Another Period of One (1) Year
Board Regulation
No. 3		 Mandatory Registration of Private and/or Government Entities Providing Narcotics Detection Dog Services and Accreditation of Narcotics Detection Dogs
Series 2023
Board Regulation No. 1 Extending the Grant of the Provisional Removal of Lianhua Qingwen from the List of Dangerous Drugs for Another Period of One (1) Year
Board Regulation No. 2

Amending Board Regulation No. 6, Series of 2019, Protocol When Handling Children Allegedly Involved in Dangerous Drugs

Annex A: Process Flow on HANDLING CHILDREN ALLEGEDLY INVOLVED IN DANGEROUS DRUGS
Board Regulation No. 3 Amending Board Regulation No. 3, Series of 2018, Specifically Converting the Committee on Reclassification, Addition or Removal of Any Drugs/Substances from The List of  Dangerous Drugs/Controlloed Precursors to a Technical Working Group (TWG)
Board Regulation No. 4 Guidelines for Drug Profiling
Board Regulation No. 5 Amending Dangerous Drugs Board Regulations No. 1, Series of 2016 and No. 3, Series of 2021 Re: Guidelines in the Implementation of “Operation: Lawmen”
Board Regulation No. 6 Amending Further Board Regulation No. 5, Series of 2003, Entitled: Guidelines in the Implementation of Operation: “Private Eye”, as Amended
Series 2022
Board Regulation No. 1 Extending the Grant of the Provisional Removal of Lianhua Qingwen From the List of Dangerous Drugs for Another Period of One (1) Year
Board Regulation No. 2 Amending Board Regulation No. 8 Series of 2021 Entitled “Authorizing the Bureau of Jail Management and Penology to Operate Jail-Based Drug Reformation Centers
Board Regulation No. 3 Enhancing the Balay Silangan Reformation Program (BSRP) Repealing for such Purpose Board Regulation No. 2, Series of 2018
Board Regulation No. 4

Inclusion of Isotonitazene in the list of Dangerous Drugs
Board Regulation No. 5

Inclusion of Diphenidine in the list of Dangerous Drugs
Board Regulation No. 6

Inclusion of Clonazolam in the list of Dangerous Drugs
Board Regulation No. 7

Inclusion of Diclazepam in the list of Dangerous Drugs
Board Regulation No. 8

Inclusion of Flubromazolam in the list of Dangerous Drugs
Series 2021

 

Board Regulation No. 1 Provisional Removal of Lianhua Qingwen from the List of Dangerous Drugs for a Period of One (1) Year
Board Regulation No. 2 Granting of Moratorium on the Implementation of Regulation No. 2, Series of 2020 (Subject: Guidelines on the Nationwide Implementation of Drug Clearing Program in Controlled Facilities for Persons Deprived of Liberty) in All Controlled Facilities
Board Regulation No. 3 Amending Certain Sections of Board Regulation No. 1 Series of 2016, Entitled: Guidelines in the Implementation of “Operation: Lawmen”
Board Regulation No. 4 Sustaining the Implementation of Barangay Drug Clearing Program (BDCP) and Repealing for Such Purpose Board Regulation No. 3, Series of 2017
Board Regulation No. 5 Allowing the Use of Ordinary Prescription in Triplicate Form to Prescribe Esketamine Single-Use Nasal Spray Device for Treatment-Resistant Depression
Board Regulation No. 6 Guidelines on the Implementation of Section 20 of RA 9165, or the Comprehensive Dangerous Drugs Act of 2002, as amended, Specifically the Last Paragraph Thereof, Covering the Necessary Cost for the Maintenance and Preservation of Seized Item/s Pending Trial of the Case, and the Subsequent Award of the Confiscated Property/Items of Lawful Commerce in Favor of the Operating Unit and for Other Lawful Purposes
Board Regulation No. 7 Amending Section 11 (d) of DDB Regulation No. 5, Series of 2003, entitled: Guidelines in the Implementation of Operation: “Private Eye”
Board Regulation No. 8 Authorizing the Bureau of Jail Management and Penology to Operate Jail-Based Reformation Centers
Series 2020
Board Regulation No. 1 Immediate Adoption of Changes in the Scope of Control of Substances Pursuant to the Three (3) United Nations International Drug Conventions
Board Regulation No. 2

Guidelines in the Nationwide Implementation of Drug Clearing Program in Controlled Facilities for Persons Deprived of Liberty
Board Regulation No. 3 Placing Drug Products Containing Cannabidiol (CBD) with no more than 0.1 percent Tetrahydrocannabinol in Schedule 4 of the Philippine Schedule
Board Regulation No. 4

Guidelines for the Oversight of General Interventions (GI) and Community-Based Drug Rehabilitation Programs (CBDRP) Implemented and Adopted by the Local Government Units at Various Levels
Series 2019
Board Regulation No. 1 Implementing Rules and Regulations Governing the Accreditation of Drug Rehabilitation Practitioners
Board Regulation No. 2 Implementing Rules and Regulations Governing the Accreditation of Drug Abuse Treatment and Rehabilitation Centers
Board Regulation No. 3 Classification of Plants that are Listed in 1961 & 1971 as Dangerous Drugs
Board Regulation No. 4 Inclusion of GBL, and All Compounds,….in the List of Dangerous Drugs
Board Regulation No. 5 SK Step Up Guidelines in Institutionalizing Uniform preventive Education
Board Regulation No. 6 Protocol When Handling Children Allegedly Involved in Dangerous Drugs
Board Regulation No. 7

Consolidated Revised Rules Governing Access to Treatment and Rehabilitation Programs and Services
Board Regulation No. 8 Requirements for the Issuance of a License to Acquire, Possess, and Use Unregistered Drug Products Containing Dangerous Drugs for Personal Use
Series 2018

Series 2018

Board Regulation No. 1 Amending Section 1 of Board Regulation No. 4, Series of 2005 “Reclassifying Ephedrine and Pseudoephedrine as Dangerous Drugs” by including the Isomers and Salts of Isomers of Ephedrine and Pseudoephedrine and by including further their Halogenated and Alkylated forms thereof and the Salts, Isomers, and Salts of Isomers of these forms as well as any material, compound, mixture or preparation containing the same, in the list of Dangerous Drugs
Board Regulation No. 2 Balay Silangan – Guidelines for Community Involvement in Reforming Drug Offenders into Self-sufficient and Law-abiding Members of Society
Board Regulation No. 3 Amending Section 3 (2) of Board Regulation No. 1, Series of 2014 and Creating the Committee on Reclassification, Addition or Removal of any Drug/Substance from the List of Dangerous Drugs/Controlled Precursors and Essential Chemicals
Board Regulation No. 4 Inclusion of 4-Methylethcathinone (4-MEC) in the List of Dangerous Drugs
Board Regulation No. 5 Inclusion of 5F-APINACA (5-F-AKB-48) in the List of Dangerous Drugs
Board Regulation No. 6 Inclusion of Ethylone in the List of Dangerous Drugs
Board Regulation No. 7 Inclusion of Ethylphenidate in the List of Dangerous Drugs
Board Regulation No. 8 Inclusion of MDMB-CHMICA in the List of Dangerous Drugs
Board Regulation No. 9 Inclusion of Methiopropamine (MPA) in the List of Dangerous Drugs
Board Regulation No. 10 Inclusion of Pentedrone in the List of Dangerous Drugs
Board Regulation No. 11 Inclusion of XLR-11 in the List of Dangerous Drugs
Board Regulation No. 12 Amending Section 2, Article II and Section 7(e), Article IV of Board Regulation No. 5 Series of 2003, Entitled: Guidelines in the Implementation of “Operation: Private Eye”, as Further Amended by DDB Board Regulation No. 1 Series of 2005 and DDB Regulation No. 4 Series of 2007
Board Regulation No. 13 Establishment and Instituitionalization of Drug-Free Workplace Policies in all Government Offices, Including the Conduct of Authorized Drug Testing for Elective Local Officials and Appointive Public Officers and for other Purposes
Series 2017
Board Regulation No. 1 Amending Certain Sections of Board Regulation No. 10, Series of 2007, Entitled: “Uniform Drug Inventory and Tracking System” 
Board Regulation No. 2 Adopting the Civil Service Commission Sanction of Dismissal at First Offense for Employees or Officials in the Public Sector Who Are Tested And Found Positive for Illegal Drugs in the Amendment of Sanctions Under Section 2 of Board Regulation No. 2, Series of 2004
Board Regulation No. 3 Strengthening the Implementation of Barangay Drug Clearing Program
Series 2016
Board Regulation No.1 Guidelines in the Implementation of Operation: “Lawmen”
Board Regulation No.2 Amending Section 2 of Board Regulation No. 2, Series of 2007 Entitled “Providing for Revised Guidelines in the Conduct of Barangay Drug-Clearing Operations”
Board Regulation No.3

Guidelines on Handling Voluntary Surrender of Drug Personalities

Attachment of Board Regulation No. 3, Series of 2016 (Voluntary Surrender Forms)
Board Regulation No.4 Oplan Sagip – Guidelines on Voluntary Surrender of Drug Users and Dependents and Monitoring Mechanism of Barangay Anti-Drug Abuse Campaigns
Board Regulation No.5 Inclusion of Acetylfentanyl in the List of Dangerous Drugs
Board Regulation No.6 Inclusion of 1- cyclohexyl-4(1,2-diphenylethyl) piperazine or MT-45 in the List of Dangerous Drugs
Board Regulation No.7 Inclusion of methoxetamine or MXE in the List of Dangerous Drugs
Board Regulation No.8 Inclusion of para-methoxymethlamphetamine or PMMA in the List of Dangerous Drugs
Board Regulation No.9 Inclusion of A-Pyrrolidinovalerophenone or A-PVP in the List of Dangerous Drugs
Board Regulation No.10 Inclusion of para-methyl-4-methylaminorex or 4,4′-DMAR in the List of Dangerous Drugs
Board Regulation No.11 Inclusion of phenazepam in the List of Dangerous Drugs
Series 2015
Board Regulation No.1 

Inclusion of ALPHA-PHENYLACETOACETONITRILE (“APAAN”) in the list of Controlled Precursors and Essential Chemicals
Board Regulation No.2 

Inclusion of 1, 2-DIMETHYL-3-PHENYL AZIRIDINE and its CIS and TRANS ISOMERS in the list of Controlled Precursors and Essential Chemicals
Board Regulation No.3 

Inclusion of SALVIA DIVINORUM, its resin, extract, tinctures or other forms and / or any part or portion thereof in the list of Dangerous Drugs
Series 2014
Board Regulation No.1 

Comprehensive Amendments to Board Regulation No. 3 Series 2003, “Comprehensive Guidelines on Importation, Distribution, Manufacture, Prescription, Dispensing and Sale of, and Other Lawful Acts in Connection with Any Dangerous Drugs, Controlled Precursors and Essential Chemicals and Other Similar or Analogous Substances”, as Amended, and Other Related Board Issuances. (This Board Regulation will take effect on March 13, 2015)
Series 2013
Board Regulation No.1  Amending Board Regulation No. 1, Series 2002, entitled “Guidelines on the Custody and Disposition of Seized Dangerous Drugs, Controlled Precursors and Essential Chemicals, and Laboratory Equipment” and for Other Purposes.
Board Regulation No.2  Inclusion of Methylephedrine in the list of dangerous drugs.
DRAFT PROPOSED AMENDMENT of Board Regulation No.3 Comprehensive Amendments to Board Regulation No. 3 s 2003, “Comprehensive Guidelines on importation, distribution, manufacture, prescription, dispensing and sale of, and other lawful acts in connection with any dangerous drugs, controlled precursors and essential chemicals and other similar or analogous substances”, as amended, and other related Board issuances
Board Regulation No. 4 Series of 2013 Amendment to Board Regulation No. 7, Series of 2003 Entitled “General Guidelines for the Implementation of Mandatory Drug Testing to Officers and Members of the Military, Police and Other Law Enforcement Agencies”
Series 2010
Board Regulation No.1 Inclusion of Nalbuphine Hydrochloride in the List of Dangerous Drugs  
Series 2009
Board Regulation No.1 Guidelines for the Rehabilitation of First Time Offenders Under Section 15 of RA 9165 Who Are Not Drug Dependents
Board Regulation No.2 Implementing Guidelines for the Implementation of Board Regulation No. 6, Series of 2007, entitled Classifying Toluene-Based Contact Cement Products Without at Least Five Percent (5%) Mustard Oil Content as Dangerous Drugs
Board Regulation No.3 General Guidelines for the Conduct of Random Drug Testing for Students of Secondary, Tertiary, Vocational and Technical Schools, Amending Board Regulation No.6, Series of 2003
Board Regulation No.4

Amending Section 18 and 19, Article III of Board Regulation No.3, Series of 2003, entitled “Comprehensive Guidelines on Importation, Distribution, Manufacture, Prescription, Dispensing and Sale of, and Other Lawful Acts in connection with, any Dangerous Drugs, Controlled Precursors and Essential Chemicals and Other Similar or Analogous Substances”
Board Regulation No.5  Inclusion of N-Benzylpiperazine (BZP) in the List of Dangerous Drugs

 

Series 2008
Board Regulation No.1 Inclusion of Oripavine in the List of Dangerous Drugs
Board Regulation No.2 Inclusion of Amineptine in the List of Dangerous Drugs
Board Regulation No.3 Amending Board Regulation No.1, Series of 2007 entitled “Guidelines on the Disposition of Confiscated, Seized and/or Surrendered Dangerous Drugs, Plant Sources of Dangerous Drugs, Controlled Precursors and Essential Chemicals, Instruments/Paraphernalia, and/or Laboratory Equipment in connection with Cases under Investigation, Preliminary Investigation or Reinvestigation
Board Regulation No.4 Amending Board Regulation No.4, Series of 2003 entitled “Implementing Rules and Regulations Governing Accreditation of Drug Abuse Treatment and Rehabilitation Centers and Accreditation of Center Personnel” 
Board Regulation No.5 Creating the Committee on Appeals of the Board and Prescribing the Procedures in Making an Appeal 
Board Regulation No.6 Guidelines on the Transfer/Re-assignment of Police Witnesses
Series 2007
Board Regulation No.1 Guidelines on the Disposition of Confiscated, Seized and/or Surrendered Dangerous Drugs, Plant Sources of Dangerous Drugs, Controlled Precursors and Essential Chemicals, Instruments/Paraphernalia, and/or Laboratory Equipment in connection with Cases under Investigation, Preliminary Investigation or Reinvestigation
Board Regulation No.2

Providing for Revised Guidelines in the Conduct of Barangay Drug-Clearing Operations
Board Regulation No.3 Rules Governing Voluntary Confinement for Treatment and Rehabilitation of Drug Dependents
Board Regulation No.4 Amending certain Sections of Board Regulation No.5, Series of 2003, entitled Guidelines in the Implementation of Operation “Private Eye” as amended by Board Regulation No.4, Series of 2006
Board Regulation No.5 Institutionalizing the Barkada Kontra Droga Program
Board Regulation No.6 Classifying Toluene-Based Contact Cement Products Without at Least Five Percent (5%) Mustard Oil Content as Dangerous Drugs
Board Regulation No.7 Amending Board Regulation No.3, Series of 2003, entitled “Comprehensive Guidelines on Importation, Distribution, Manufacture, Prescription, Dispensing, and Sale of, and other Lawful Acts in connection with, any Dangerous Drugs, Controlled Precursors and Essential Chemicals and other Similar or Analogous Substances”
Board Regulation No.8 Amending Board Regulation No.2, Series of 2003, entitled “Implementing Rules and Regulations Governing Accreditation of Drug Testing Laboratories in the Philippines” 
Board Regulation No.9 Amending Board Regulation No.1, Series of 2004, entitled “Prescribing Drug Test Fee for Government-Owned and Private Drug Testing Laboratories Accredited by the Department of Health” 
Board Regulation No.10 Uniform Drug Inventory and Tracking System 
Series 2006
Board Regulation No.1 Guidelines in the Implementation of the Aftercare Program for Recovering Drug Dependents
Board Regulation No.2 Regulation Governing the Implementation of Section 57 (Probation and Community Service under the Voluntary Submission Program) and Section 70 (Probation or Community Service for a First-time Minor Offender in Lieu of Imprisonment) of RA 9165 
Board Regulation No.3 Guidelines for the Drug Proficiency Testing (PT) Program for Drug Testing Laboratories (DTLs)
Board Regulation No.4 Amending Board Regulation No.5, Series of 2003, Entitled Guidelines in the Implementation of Operation “Private Eye” 
Board Regulation No.5 Imposing Fines and other Sanctions for Violations Committed on the Pertinent Provisions of Board Regulation No.3, Series of 2003 
Board Regulation No.6 Prescribing the Procedures for Appeal regarding the Implementation of Board Regulation No.3, Series of 2003 
Board Regulation No.7 Institutionalizing the Dangerous Drugs Board Integrated Drug Abuse Data Information Network (DDB IDADIN) 
Series 2005
Board Regulation No.1 Amending Board Regulation No.5 Series of 2003, entitled Guidelines in the Implementation of “Operation: Private Eye”
Board Regulation No.2 Rules on the Suspension of Sentence of a First-time Minor Drug Offender
Board Regulation No.3 Inclusion of Ketamine in the List of Dangerous Drugs and Amending Section 32-6(b) of Board Regulation No.3, Series 2003 and in the List of Dangerous Drugs to be Prescribed in a Single Applicable Prescription by a Licensed Practitioner
Board Regulation No.4 Reclassifying Ephedrine and Pseudophedrine as Dangerous Drugs
Board Regulation No.5 Inclusion of Thionyl Chloride in the List of Controlled Precursors and Essential Chemicals
Series 2004
Board Regulation No.1

Prescribing Drug Test Fee for Government-owned and Private Drug Testing Laboratories Accredited by the Department of Health
Board Regulation No.2 Guidelines for the Formulation and Implementation of a Drug-free Workplace Program and the Conduct of Authorized Drug Testing by all Offices, Bureaus, and Agencies of the National and Local Governments, Government-owned and Controlled Corporations and other Institutes of Learning including the State Colleges and Universities
Board Regulation No.3

Prescribing the Confirmatory Drug Test Fee to be Paid by the Screening Drug Testing Laboratories to the Department of Health (DOH) Accredited Confirmatory Laboratories
Series 2003
Board Regulation No.1 Implementing Guidelines Governing the Operationalization of the Special Drug Education Centers
Board Regulation No.2 Implementing Rules and Regulations Governing Accreditation of Drug Testing Laboratories in the Philippines 
Board Regulation No.3  Comprehensive Guidelines on Importation, Distribution, Manufacture, Prescription, Dispensing and Sale of, and Other Lawful Acts in connection with any Dangerous Drugs, Controlled Precursors and Essential Chemicals and other Similar or Analogous Substances 
Board Regulation No.4  Implementing Rules and Regulations Governing Accreditation of Drug Abuse Treatment and Rehabilitation Centers and Accreditation of Center Personnel 
Board Regulation No.5  Guidelines in the Implementation of Operation “Private Eye” 
Board Regulation No.6  General Guidelines for the Conduct of Random Drug Testing for Secondary and Tertiary Students 
Board Regulation No.7  General Guidelines for the Implementation of Mandatory Drug Testing to officers and members of the Military, Police, and other Law Enforcement Agencies 

Board Regulation No.8

 Guidelines for the Implementation of a Drug-free Workplace Policies and Programs for the Private Sector 
Board Regulation No.9  Adopting and Enforcing All Previously Issued Dangerous Drugs Board Resolutions/Regulations and other Issuances that are not Inconsistent with the Provisions of RA 9165 otherwise known as the Comprehensive Dangerous Drug Act of 2002 
Board Regulation No.10  Guidelines for the Implementation of Drug Testing of Driver’s License Applicants 

Board Regulation No.11

 Guidelines for the Implementation of Mandatory Drug Testing to Applicants of Firearms License and Permit to Carry Firearms outside of Residence
Board Regulation No.12  Re-use of the Polyethylene Bottles for Urine Collection in Drug Testing 
Series 2002
Board Regulation No.1 Guidelines on the Custody and Disposition of Seized Dangerous Drugs, Controlled Precursors and Essential Chemicals and Laboratory Equipment
Board Regulation No.2 Conduct of Controlled Delivery Operations